Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Vitiligo. Pathogenesis and treatment.

M D Njoo¹, W Westerhof

¹Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

American Journal of Clinical Dermatology

|November 14, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry Study.

Drugs & aging·2022

Same author

Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Same author

Twenty-year follow-up using a postal survey of childhood vitiligo treated with narrowband ultraviolet B phototherapy.

The British journal of dermatology·2017

Same author

Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.

The British journal of dermatology·2016

Same author

Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort.

The British journal of dermatology·2016

Same author

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry.

The British journal of dermatology·2016

Vitiligo is a skin disorder causing white patches due to pigment cell loss, affecting 0.5% of the global population. Current treatments focus on halting progression and repigmentation, with new therapies emerging.

Area of Science:

Dermatology
Immunology
Genetics

Background:

Vitiligo is an acquired skin disorder characterized by depigmented patches.
It affects approximately 0.5% of the global population, with unknown etiology possibly involving genetic and autoimmune factors.
The condition can cause significant cosmetic disfigurement and psychological distress.

Purpose of the Study:

To review current and emerging treatment modalities for vitiligo.
To discuss strategies for managing depigmented skin areas and improving patient quality of life.

Main Methods:

Review of existing literature on vitiligo treatments.
Highlighting novel therapeutic approaches such as narrowband UVB therapy, combination therapies, and cell transplantation.

Related Experiment Videos

Main Results:

Established treatments aim to stop disease progression and promote repigmentation.
Emerging therapies show promise in restoring skin morphology and function.
Supportive measures like sunscreens and camouflage are crucial for patient coping.

Conclusions:

Vitiligo management requires a multi-faceted approach, addressing both physical and psychological aspects.
Ongoing research into causative factors and advanced treatments is essential.
New therapeutic developments offer improved options for patients with vitiligo.